MedTrace Logo

Hydrolyzed Collagen in the Reduction of Osteoarticular Pain and Functional Limitation

NCT05149053 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-12-08

No results posted yet for this study

Summary

This randomised study evaluates the efficacy of an oral dietary supplement of Hydrolyzed Collagen in reducing pain and improving physical function in subjects with osteoarthritis.

Conditions

Interventions

DIETARY_SUPPLEMENT

Hydrolyzed Collagen

Active product was composed of Hydrolyzed Collagen, lemon flavoring, anhydrous citric acid (acidifier), calcium ascorbate (vitamin C), sucralose (sweetener) and stevia (sweetener). One 10.728 g dose provides 10 g of HC and 80 mg of vitamin C.

OTHER

Placebo

Placebo packet contained sucralose (sweetener) and stevia (sweetener) in identical proportions to the active preparation.

Sponsors & Collaborators

  • NutraResearch, SL

    collaborator UNKNOWN

  • Francisco Jose Rodriguez Velasco

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-02-26
Completion
2021-03-12

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05149053 on ClinicalTrials.gov